Development of a fluorescence-based Trypanosoma cruzi CYP51 inhibition assay for effective compound triaging in drug discovery programmes for Chagas disease
Jennifer Riley, Stephen Brand, Michael Voice, Ivan Caballero, David Calvo, Kevin D. Read (Lead / Corresponding author)
Dive into the research topics of 'Development of a fluorescence-based Trypanosoma cruzi CYP51 inhibition assay for effective compound triaging in drug discovery programmes for Chagas disease'. Together they form a unique fingerprint.